Scientists can now target the cells at the center of ALS
On Jun. 16, 2025, the Allen Institute announced that for the first time ever, scientists have developed a…
Biogen received European Commission approval for QALSODY® (tofersen), first therapy for rare, genetic form of ALS
On May 30, 2024, Biogen announced that the European Commission (EC) had granted marketing authorization under exceptional circumstances…
Abnormal proteins found in the spinal fluid of people with ALS and frontotemporal dementia
On Jan. 31, 2024, researchers at the National Institutes of Health detected abnormal proteins in the spinal fluid…
Erroneous genetic sequences identified for the first time in specific cells of ALS and frontotemporal dementia patients
On Jul. 19, 2023, a team of scientists from the Translational Genomics Research Institute (TGen), part of the…
U.S. FDA approved treatment of amyotrophic lateral sclerosis associated with a mutation in the SOD1 gene
On Apr. 25, 2023, the U.S. FDA approved Qalsody (tofersen) to treat patients with amyotrophic lateral sclerosis (ALS)…
Study identified features that may make motor neurons vulnerable to ALS
On Feb. 2, 2023, a team of researchers supported by the National Institutes of Health found evidence linking…
Researchers identified a cellular defect common to familial and sporadic forms of ALS
On Jul. 28, 2021, the National Institutes of Health announced that by studying lab-grown neurons derived from skin…
Researchers identified a cellular defect common to familial and sporadic forms of ALS
On Jul. 28, 2021, the National Institutes of Health announced that by studying lab-grown neurons derived from skin…
Scientists discovered a new genetic form of ALS in children
On Jun. 1, 2021, in a study of 11 medical-mystery patients, an international team of researchers led by…
The ALS Society of BC awarded $2 million for PROJECT HOPE to establish ALS research professorship at UBC
On May 12, 2021, the province of British Columbia provided the ALS Society of BC with $2 million…
NIH researchers linked cases of ALS and FTD to a mutation associated with Huntingtonﾒs disease
On Dec. 4, 2020, researchers at the National Institutes of Health reported that they had made a surprising…
Sigma-1 receptor structure was revealed, leading to potential ALS therapeutic agents
On April 28, 2016, Harvard researcher Andrew Kruse and collaborators first revealed the molecular structure of the sigma-1…
Institute for Applied Life Sciencesﾠ (IALS) was founded
In 2014, the Institute for Applied Life Sciences ﾠ(IALS) was founded at the University of Massachusetts Amherst with…
Baseball legend Lou Gehrig delivered the famous farewell speech bidding to fans
On Jul. 4, 1939, baseball legend Lou Gehrig delivered the famous speech bidding farewell to the ballpark and…